STOCK TITAN

Alto Neuroscience to Present at the TD Cowen 44th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Alto Neuroscience, Inc. (ANRO) CEO Amit Etkin to present at TD Cowen 44th Annual Healthcare Conference. The presentation will be available via live webcast and replay for 90 days.
Positive
  • None.
Negative
  • None.

LOS ALTOS, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced that Amit Etkin, M.D., Ph.D., founder and chief executive officer, will present a company overview at the TD Cowen 44th Annual Healthcare Conference on Tuesday, March 5, 2024, at 1:30 pm ET.

The presentation will also be available via live webcast on the Events and Presentations page in the Investors section of Alto’s website and a replay will be available for 90 days following the presentation.

About Alto Neuroscience

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto’s Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia, and other mental health conditions. For more information, visit www.altoneuroscience.com or follow Alto on X.

Investor Contact:

Nick Smith

investors@altoneuroscience.com

Media Contact:

Jordann Merkert

media@altoneuroscience.com

Source: Alto Neuroscience, Inc.

FAQ

When will Amit Etkin present at the TD Cowen 44th Annual Healthcare Conference?

Amit Etkin will present on Tuesday, March 5, 2024, at 1:30 pm ET.

Where can I watch the presentation by Amit Etkin?

The presentation will be available via live webcast on Alto's website.

How long will the replay of the presentation be available?

The replay will be available for 90 days following the presentation.

Alto Neuroscience Inc.

NYSE:ANRO

ANRO Rankings

ANRO Latest News

ANRO Stock Data

335.24M
16.23M
13.11%
37.25%
8.91%
Biotechnology
Healthcare
Link
United States of America
LOS ALTOS